You know what's more embarrassing than delaying a product launch? Delaying it because your competitor's version is just that much better.
Welcome to Meta's AI problem. The company's new model, codenamed "Avocado," was supposed to roll out and prove that Mark Zuckerberg's $40+ billion AI spending spree was worth it. Instead, it's being pushed to May or later because - and this is the kicker - it can't compete with Google's Gemini.
According to reports, Meta's AI division is now discussing the possibility of temporarily licensing Google's Gemini to power their own products. Read that again. Meta might pay Google to use their AI because Meta's own AI isn't good enough.
If you own Meta stock, this should concern you. Not because one model launch got delayed - that happens in tech all the time. But because it reveals something more fundamental: all that capital spending might not be translating into a competitive moat.
Let's talk numbers for a second. Meta has been pouring tens of billions into AI infrastructure, chips, and research. Wall Street has been willing to overlook the massive capex because the narrative is that AI will transform Facebook and Instagram into something even more valuable. But if Meta can't even build a competitive AI model, what exactly are investors paying for?
The performance gap is real. According to sources, Avocado currently falls between Google's Gemini 2.5 and Gemini 3 - meaning it's not even close to Google's latest generation. For a company that's supposed to be at the cutting edge of AI, that's not good enough.
Here's my cynical take: Meta is discovering what a lot of companies are about to learn the hard way. Throwing money at AI doesn't guarantee results. You need the right talent, the right data, and frankly, some luck. Google has been doing this longer and they're better at it. That's not an insult, it's just reality.
The question for investors is whether this is a temporary setback or a sign that Meta's AI dreams are going to cost more and deliver less than promised. The stock is priced for AI domination. If they end up being a licensing someone else's tech, that's a very different valuation story.

